About Cardurion Pharmaceuticals
Transforming the treatment of cardiovascular disease and heart failure
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B
Global Headquarters
Burlington, United States
Year Founded
2016
Team Size
11–50 employees
Tracked Since
Nov 8, 2026
Web & Domain Identity
Official Website
cardurion.com
Domain Registered Date
Undisclosed
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Company Profile
Company Milestones & Timeline
- Capital Raise
Raised $260,000,000 · Series-B
Backed by Ascenta Capital
- Milestone
Company founded
Burlington, United States
Investors & Backers
Ascenta Capital
Lead
Bain Capital Life Sciences
Bain Capital Private Equity
Blue Owl Capital
Delos Capital
Digitalis Ventures
Farallon Capital Management
Fidelity
GV
Invus
Millennium Management
NEA
Funding History
Series-B equity
· Jul 16, 2024
Round backers: Ascenta Capital
$260,000,000 fundraisingfox.com
Founders & Leadership
Elizabeth Radcliffe
Chief Financial Officer
Work email & phone locked
Unlock →
Howard Surks
Chief Medical Officer and Head of Translational Medicine
Work email & phone locked
Unlock →
Marcia Moore
Chief Operating Officer
Work email & phone locked
Unlock →
Michael Mendelsohn
Founder
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allTesorai
tesorai.com
Seed Nov 2026
Commit Biologics
commitbio.com
Seed Aarhus · Nov 2026
Human Biome
human-biome.com
Series-A Warsaw · Nov 2026
MedInTech
medintech.co.kr
Series-B Seoul · Nov 2026
Ace Padel
acepadel.com
Seed Bradenton, United States · Nov 2026
Mentix
mentix.world
Pre-Seed London, United Kingdom · Nov 2026